CCL19 and CCL21 induce a potent proinflammatory differentiation program in licensed dendritic cells

被引:233
作者
Marsland, BJ
Bättig, P
Bauer, M
Ruedl, C
Lässing, U
Beerli, RR
Dietmeier, K
Ivanova, L
Pfister, T
Vogt, L
Nakano, H
Nembrini, C
Saudan, P
Kopf, M
Bachmann, MF
机构
[1] Cytos Biotechnol AG, CH-8952 Zurich, Switzerland
[2] Swiss Fed Inst Technol, Dept Environm Sci, CH-8092 Zurich, Switzerland
[3] Duke Univ, Ctr Med, Dept Med, Durham, NC 27710 USA
关键词
D O I
10.1016/j.immuni.2005.02.010
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
Dendritic cells (DCs) are key instigators of adaptive immune responses. Using an alphaviral expression cloning technology, we have identified the chemokine CCL19 as a potent inducer of T cell proliferation in a DC-T cell coculture system. Subsequent studies showed that CCL19 enhanced T cell proliferation by inducing maturation of DCs, resulting in upregulation of costimulatory molecules and the production of proinflammatory cytokines. Moreover, CCL19 programmed DCs for the induction of T helper type (Th) 1 rather than Th2 responses. Importantly, only activated DCs that migrated from the periphery to draining lymph nodes, but not resting steady-state DCs residing within lymph nodes, expressed high levels of CCR7 in vivo and responded to CCL19 with the production of proinflammatory cytokines. Migrating DCs isolated from mice genetically deficient in CCL19 and CCL21 (plt/plt) presented an only partially mature phenotype, highlighting the importance of these chemokines for full DC maturation in vivo. Our findings indicate that CCL19 and CCL21 are potent natural adjuvants for terminal activation of DCs and suggest that chemokines not only orchestrate DC migration but also regulate their immunogenic potential for the induction of T cell responses.
引用
收藏
页码:493 / 505
页数:13
相关论文
共 65 条
[1]   Toll-like receptors and innate immunity [J].
Akira, S .
ADVANCES IN IMMUNOLOGY, VOL 78, 2001, 78 :1-56
[2]   Immature dendritic cells phagocytose apoptotic cells via αvβ5 and CD36, and cross-present antigens to cytotoxic T lymphocytes [J].
Albert, ML ;
Pearce, SFA ;
Francisco, LM ;
Sauter, B ;
Roy, P ;
Silverstein, RL ;
Bhardwaj, N .
JOURNAL OF EXPERIMENTAL MEDICINE, 1998, 188 (07) :1359-1368
[3]   Molecular mimicry of a CCR5 binding-domain in the microbial activation of dendritic cells [J].
Alberti, J ;
Valenzuela, JG ;
Carruthers, VB ;
Hieny, S ;
Andersen, J ;
Charest, H ;
Sousa, CRE ;
Fairlamb, A ;
Ribeiro, JM ;
Sher, A .
NATURE IMMUNOLOGY, 2003, 4 (05) :485-490
[4]   Recognition of double-stranded RNA and activation of NF-κB by Toll-like receptor 3 [J].
Alexopoulou, L ;
Holt, AC ;
Medzhitov, R ;
Flavell, RA .
NATURE, 2001, 413 (6857) :732-738
[5]   CCR5 provides a signal for microbial induced production of IL-12 by CD8α+ dendritic cells [J].
Aliberti, J ;
Sousa, CRE ;
Schito, M ;
Hieny, S ;
Wells, T ;
Huffnagle, GB ;
Sher, A .
NATURE IMMUNOLOGY, 2000, 1 (01) :83-87
[6]   Balancing protective immunity and immunopathology [J].
Bachmann, MF ;
Kopf, M .
CURRENT OPINION IN IMMUNOLOGY, 2002, 14 (04) :413-419
[7]   TRANCE, a tumor necrosis factor family member critical for CD40 ligand-independent T helper cell activation [J].
Bachmann, MF ;
Wong, BR ;
Josien, R ;
Steinman, RM ;
Oxenius, A ;
Choi, Y .
JOURNAL OF EXPERIMENTAL MEDICINE, 1999, 189 (07) :1025-1031
[8]   Immunobiology of dendritic cells [J].
Banchereau, J ;
Briere, F ;
Caux, C ;
Davoust, J ;
Lebecque, S ;
Liu, YT ;
Pulendran, B ;
Palucka, K .
ANNUAL REVIEW OF IMMUNOLOGY, 2000, 18 :767-+
[9]   Toll-like receptors: how they work and what they do [J].
Beutler, B .
CURRENT OPINION IN HEMATOLOGY, 2002, 9 (01) :2-10
[10]   Efficient targeting of protein antigen to the dendritic cell receptor DEC-205 in the steady state leads to antigen presentation on major histocompatibility complex class I products and peripheral CD8+ T cell tolerance [J].
Bonifaz, L ;
Bonnyay, D ;
Mahnke, K ;
Rivera, M ;
Nussenzweig, MC ;
Steinman, RM .
JOURNAL OF EXPERIMENTAL MEDICINE, 2002, 196 (12) :1627-1638